Company Overview
- Headquarters
- 701 Gateway Boulevard, South San Francisco CA
- Website
- oxigene.com
- Employees
- 39
- Founded in
- 1996
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$1B
Who is OXiGENE Inc
OXiGENE Inc. is a biopharmaceutical company headquartered in South San Francisco, California. The company employs 39 people and generates approximately $1 million in annual revenue. OXiGENE focuses on developing vascular targeted therapies (VTTs) for cancer treatment. Their investigational drugs, known as vascular disrupting agents (VDAs), aim to disrupt the blood supply to tumors, preventing their growth and spread. OXiGENE's VTTs work by targeting and destroying the blood vessels that nourish tumors, effectively starving them of oxygen and nutrients. The company's approach to cancer therapy involves combining VDAs with other anti-angiogenic agents (AAs) to create a synergistic effect. This multi-pronged strategy aims to significantly improve cancer treatment outcomes by targeting both the tumor cells and the blood vessels that support them. OXiGENE believes that their VTTs have the potential to revolutionize cancer care by offering a new and effective way to combat this devastating disease. For more information about OXiGENE and their innovative therapies, please visit their website at oxigene.com.
Companies Similar to OXiGENE Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to OXiGENE Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1M | 11 | 2007 | ||
| 1M | 4 | |||
| 1M | 4 | Washington, WA | 1994 | |
| 1M | 32 | New York, NY | 1983 | |
| 1M | 3 |